Immucor out of Norcross, Georgia won FDA approval to market the 4th generation NEO blood banking system. The system is fully automated and developed for use by high throughput labs.
Features from the product page:
NEO delivers the highest type-and-screen throughput in the market. true continuous access allows operators to add samples or resources anytime.
NEO automates Immucor’s patented CAPTURE® technology with proven clinical performance and a comprehensive process control strategy, providing trustworthy test results.
NEO’s dynamic scheduler, with new stat priority handling offers superior workflow management.
Broad test menu:
Antibody Identification (Primary Panel, D Pos Panel, D Neg Panel)
Antibody Screening (2-cell, 3-cell, & Pooled)
Platelet Antibody Screen
Press release: Immucor Announces FDA Clearance of NEO, the Company’s Fourth Generation Automated Instrument…
Product page: NEO…